Results 141 to 150 of about 1,482,126 (355)

Profiling Preexisting Antibodies in Patients Treated With Anti–PD-1 Therapy for Advanced Non–Small Cell Lung Cancer

open access: yesJAMA Oncology, 2019
Importance Administration of anti–programmed cell death protein 1 (anti–PD-1) is now standard therapy in advanced non–small cell lung cancer (NSCLC).
Y. Toi   +17 more
semanticscholar   +1 more source

Sustained rescue of seizure control in patients with highly refractory chronic epilepsy using empiric immunotherapy

open access: yesEpilepsia, EarlyView.
Abstract Objective Following emerging evidence of autoimmune‐associated seizures in medication‐refractory epilepsy, we began offering a trial of immunotherapy to selected patients. Here, we review this approach's treatment response, predictive clinical features, and utility.
Elisabeth Doran   +4 more
wiley   +1 more source

Immunoglobulin E and systemic lupus erythematosus

open access: yesBrazilian Journal of Medical and Biological Research, 2004
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by intense polyclonal production of autoantibodies and circulating immune complexes. Some reports have associated SLE with a Th2 immune response and allergy.
Atta A.M.   +3 more
doaj  

Antinuclear antibodies in primary osteoarthritis of the knee [PDF]

open access: yes, 2012
Objective: Although osteoarthritis (OA) is widely accepted as a degenerative disease, autoimmune processes are believed to be involved in the pathogenesis.
Hussein, Heselynn   +3 more
core  

Evaluating the prevalence and severity of metabolic dysfunction‐associated steatotic liver disease in patients with type 2 diabetes mellitus in primary care

open access: yesJournal of Internal Medicine, EarlyView.
Abstract Background and aims The prevalence of metabolic dysfunction‐associated steatotic liver disease (MASLD) has increased during the epidemic of obesity. Type 2 diabetes mellitus (T2DM) is associated with progressive MASLD. Therefore, many guidelines recommend screening for MASLD in patients with T2DM.
Wile Balkhed   +18 more
wiley   +1 more source

Haematologic Data Improves Long‐Term Prediction Accuracy of Artificial Intelligence Models for Temporomandibular Disorders

open access: yesJournal of Oral Rehabilitation, EarlyView.
ABSTRACT Objectives This study aimed to develop and evaluate an artificial intelligence (AI) model to predict long‐term treatment outcomes in temporomandibular disorder (TMD) patients using clinical data and verify the value of adding haematologic data in enhancing predictive accuracy.
Moon Jong Kim   +4 more
wiley   +1 more source

Longitudinal Monitoring of SARS-CoV-2 IgM and IgG Seropositivity to Detect COVID-19. [PDF]

open access: yes, 2020
BackgroundSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a novel beta-coronavirus that has recently emerged as the cause of the 2019 coronavirus pandemic (COVID-19).
Fitzgerald, Robert L   +5 more
core  

Evaluating plasma antinuclear autoantibody profile as a prognostic biomarker in lymphoma

open access: yesBMC Cancer
Background Research on the antinuclear antibodies (ANA) profile across different pathological subtypes of lymphoma was limited. Our study aimed to assess ANA profile and investigate its potential prognostic value in lymphoma.
Cuiling Zheng   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy